5am Ventures Iv, L.p. - Net Worth and Insider Trading
5am Ventures Iv, L.p. Net Worth
The estimated net worth of 5am Ventures Iv, L.p. is at least $74 Million dollars as of 2024-12-27. 5am Ventures Iv, L.p. is the 10% Owner of IDEAYA Biosciences Inc and owns about 2,663,066 shares of IDEAYA Biosciences Inc (IDYA) stock worth over $69 Million. 5am Ventures Iv, L.p. is the of Crinetics Pharmaceuticals Inc and owns about 94,489 shares of Crinetics Pharmaceuticals Inc (CRNX) stock worth over $5 Million. 5am Ventures Iv, L.p. is also the 10% Owner of Homology Medicines Inc and owns about 251,996 shares of Homology Medicines Inc (FIXX) stock worth over $235,541. Besides these, 5am Ventures Iv, L.p. also holds Aprea Therapeutics Inc (APRE) . Details can be seen in 5am Ventures Iv, L.p.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that 5am Ventures Iv, L.p. has not made any transactions after 2020-12-22 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of 5am Ventures Iv, L.p.
5am Ventures Iv, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, 5am Ventures Iv, L.p. owns 6 companies in total, including Aprea Therapeutics Inc (APRE) , Crinetics Pharmaceuticals Inc (CRNX) , and IDEAYA Biosciences Inc (IDYA) among others .
Click here to see the complete history of 5am Ventures Iv, L.p.’s form 4 insider trades.
Insider Ownership Summary of 5am Ventures Iv, L.p.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| APRE | Aprea Therapeutics Inc | 2020-10-05 | 10 percent owner |
| CRNX | Crinetics Pharmaceuticals Inc | 2019-06-21 | 10 percent owner |
| IDYA | IDEAYA Biosciences Inc | 2020-11-11 | 10 percent owner & Former 10% holder |
 | | 2020-12-22 | 10 percent owner |
| | 2017-11-16 | 10 percent owner |
| | 2021-12-03 | 10 percent owner |
5am Ventures Iv, L.p. Latest Holdings Summary
5am Ventures Iv, L.p. currently owns a total of 4 stocks. Among these stocks, 5am Ventures Iv, L.p. owns 2,663,066 shares of IDEAYA Biosciences Inc (IDYA) as of November 11, 2020, with a value of $69 Million and a weighting of 92.8%. 5am Ventures Iv, L.p. owns 94,489 shares of Crinetics Pharmaceuticals Inc (CRNX) as of June 21, 2019, with a value of $5 Million and a weighting of 6.87%. 5am Ventures Iv, L.p. also owns 251,996 shares of Homology Medicines Inc (FIXX) as of December 22, 2020, with a value of $235,541 and a weighting of 0.32%. The other 1 stocks Aprea Therapeutics Inc (APRE) have a combined weighting of 0.02% among all his current holdings.
Latest Holdings of 5am Ventures Iv, L.p.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| IDYA | IDEAYA Biosciences Inc | 2020-11-11 | 2,663,066 | 25.86 | 68,866,887 |
| CRNX | Crinetics Pharmaceuticals Inc | 2019-06-21 | 94,489 | 53.92 | 5,094,847 |
| FIXX | Homology Medicines Inc | 2020-12-22 | 251,996 | 0.93 | 235,541 |
| APRE | Aprea Therapeutics Inc | 2020-10-05 | 3,798 | 3.37 | 12,799 |
Holding Weightings of 5am Ventures Iv, L.p.
5am Ventures Iv, L.p. Form 4 Trading Tracker
According to the SEC Form 4 filings, 5am Ventures Iv, L.p. has made a total of 1 transactions in IDEAYA Biosciences Inc (IDYA) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in IDEAYA Biosciences Inc is the sale of 800,000 shares on November 11, 2020, which brought 5am Ventures Iv, L.p. around $11 Million.
According to the SEC Form 4 filings, 5am Ventures Iv, L.p. has made a total of 0 transactions in Crinetics Pharmaceuticals Inc (CRNX) over the past 5 years. The most-recent trade in Crinetics Pharmaceuticals Inc is the sale of 250,000 shares on June 21, 2019, which brought 5am Ventures Iv, L.p. around $6 Million.
According to the SEC Form 4 filings, 5am Ventures Iv, L.p. has made a total of 2 transactions in Homology Medicines Inc (FIXX) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Homology Medicines Inc is the sale of 27,778 shares on December 22, 2020, which brought 5am Ventures Iv, L.p. around $6 Million.
More details on 5am Ventures Iv, L.p.'s insider transactions can be found in the Insider Trading History of 5am Ventures Iv, L.p. table.Insider Trading History of 5am Ventures Iv, L.p.
- 1
5am Ventures Iv, L.p. Trading Performance
GuruFocus tracks the stock performance after each of 5am Ventures Iv, L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by 5am Ventures Iv, L.p. is 22.58%. GuruFocus also compares 5am Ventures Iv, L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by 5am Ventures Iv, L.p. within 3 months outperforms 2 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how 5am Ventures Iv, L.p.'s insider trading performs compared to the benchmark.
Performance of 5am Ventures Iv, L.p.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 15.32 | | | | | |
| Relative Return to S&P 500(%) | 11.34 | | | | | |
5am Ventures Iv, L.p. Ownership Network
5am Ventures Iv, L.p. Owned Company Details
What does Aprea Therapeutics Inc do?
Who are the key executives at Aprea Therapeutics Inc?
5am Ventures Iv, L.p. is the 10 percent owner of Aprea Therapeutics Inc. Other key executives at Aprea Therapeutics Inc include President & CEO Oren Gilad , SrVP/CFO/Prin. Fin &Acctg. Off John P. Hamill , and director & President & CEO Christian S Schade .
Aprea Therapeutics Inc (APRE) Insider Trades Summary
Over the past 18 months, 5am Ventures Iv, L.p. made no insider transaction in Aprea Therapeutics Inc (APRE). Other recent insider transactions involving Aprea Therapeutics Inc (APRE) include a net purchase of 3,900 shares made by Oren Gilad , a net purchase of 23,728 shares made by Marc Duey , and a net purchase of 1,510 shares made by John P. Hamill .
In summary, during the past 3 months, insiders sold 6,462 shares of Aprea Therapeutics Inc (APRE) in total and bought 42,590 shares, with a net purchase of 36,128 shares. During the past 18 months, 6,462 shares of Aprea Therapeutics Inc (APRE) were sold and 59,320 shares were bought by its insiders, resulting in a net purchase of 52,858 shares.
Aprea Therapeutics Inc (APRE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aprea Therapeutics Inc Insider Transactions
5am Ventures Iv, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for 5am Ventures Iv, L.p.. You might contact 5am Ventures Iv, L.p. via mailing address: 501 2nd Street, Suite 350, San Francisco Ca 94107.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
